The brain in evolution and involution.
This paper provides an overview of the phylogenetic evolution and structural organization of the basal ganglia. These large subcortical structures that form the core of the cerebral hemispheres directly participate in the control of psychomotor behavior. Neuroanatomical methods combined with transmitter localization procedures were used to study the chemical organization of the forebrain in each major group of vertebrates. The various components of the basal ganglia appear well developed in amniote vertebrates, but remain rudimentary in anamniote vertebrates. For example, a typical substantia nigra composed of numerous dopaminergic neurons that project to the striatum already exists in the brain of reptiles. Other studies in mammals show that glutamatergic cortical inputs establish distinct functional territories within the basal ganglia, and that neurons in each of these territories act upon other brain neuronal systems principally via a GABAergic disinhibitory output mechanism. The functional status of the various basal ganglia chemospecific systems was examined in animal models of neurodegenerative diseases, as well as in postmortem material from Parkinson's and Huntington's disease patients. The neurodegenerative processes at play in such conditions specifically target the most phylogenetically ancient components of the brain, including the substantia nigra and the striatum, and the marked involution of these brain structures is accompanied by severe motor and cognitive deficits. Studies of neural mechanisms involved in these akinetic and hyperkinetic disorders have led to a complete reevaluation of the current model of the functional organization of the basal ganglia in both health and disease.
Parent
A
A
Laboratoire de neurobiologie, Université Laval Robert-Giffard, Beauport, QC, Canada.
D000818:Animals; D001479:Basal Ganglia / Q000033:anatomy & histology / Q000473:pathology / Q000502:physiology; D005075:Biological Evolution; D001921:Brain / Q000033:anatomy & histology* / Q000473:pathology* / Q000502:physiology; D001927:Brain Diseases / Q000473:pathology* / Q000503:physiopathology; D001931:Brain Mapping; D006801:Humans; D019636:Neurodegenerative Diseases / Q000473:pathology* / Q000503:physiopathology; D010802:Phylogeny